Guides ARV regimen selection based on resistance testing, prior therapy, HLA-B*5701 status, and renal function. Preferred first-line: bictegravir/tenofovir AF/emtricitabine or dolutegravir + tenofovir/emtricitabine.
Guides ARV regimen selection based on resistance testing, prior therapy, HLA-B*5701 status, and renal function. Preferred first-line: bictegravir/tenofovir AF/emtricitabine or dolutegravir + tenofovir/emtricitabine
Each component has a specific meaning:
Note: Interpret the arv regimen selector result against the thresholds and context described above.
Enter the resistance testing, prior therapy, HLA-B*5701 status, renal function for the scenario you are assessing. Guides ARV regimen selection based on resistance testing, prior therapy, HLA-B*5701 status, and renal function. Preferred first-line: bictegravir/tenofovir AF/emtricitabine or dolutegravir + tenofovir/emtricitabine. Use the arv regimen selector result to inform your calculation.